Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019
|
Descrizione fisica |
1 online resource (129 pages)
|
Disciplina |
615.10289
|
Collana |
Cancer Treatment and Research
|
Soggetto topico |
Oncology
Pharmacy
Oncology
Drug Safety and Pharmacovigilance
|
ISBN |
3-319-43896-4
|
Formato |
Materiale a stampa ![](img/format/mas.png) |
Livello bibliografico |
Monografia |
Lingua di pubblicazione |
eng
|
Nota di contenuto |
Pharmacovigilance programs: Do they improve Cancer Drug Safety? -- Impact of Cost on the Safety of Cancer pharmaceuticals -- Assessing pharmaceutical safety in Geriatric Oncology -- Cancer co-Morbidity: Implications for Drug Safety -- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions? -- Pharmacovigilance of alternative medications in the Cancer Setting -- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology -- Biosimilars: Are they really safe? -- Natural Language processing: improving the identification and communication of Cancer Drug Safety -- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety -- Anatomy of Risk Evaluation and Mitigation Strategies (REMS) -- Cancer Drug Toxicity: Moving from patient to Survivor.
|
Record Nr. | UNINA-9910337507003321 |